FDA Requests More Data on Drug for Chronic Kidney Disease FDA Requests More Data on Drug for Chronic Kidney Disease

The agency sent a letter to manufacturer Tricida requesting more information on veverimer, a drug in development to treat metabolic acidosis associated with chronic kidney disease.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Nephrology News Source Type: news